Translational repression of thymidylate synthase by targeting its mRNA.
Nucleic Acids Res. 41, 4159-4170 (2013)
Resistance to drugs targeting human thymidylate synthase (TS) poses a major challenge in the field of anti-cancer therapeutics. Overexpression of the TS protein has been implicated as one of the factors leading to the development of resistance. Therefore, repressing translation by targeting the TS mRNA could help to overcome this problem. In this study, we report that the compound Hoechst 33258 (HT) can reduce cellular TS protein levels without altering TS mRNA levels, suggesting that it modulates TS expression at the translation level. We have combined nuclear magnetic resonance, UV-visible and fluorescence spectroscopy methods with docking and molecular dynamics simulations to study the interaction of HT with a region in the TS mRNA. The interaction predominantly involves intercalation of HT at a CC mismatch in the region near the translational initiation site. Our results support the use of HT-like compounds to guide the design of therapeutic agents targeting TS mRNA.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Electric Linear Dichroism ; Molecular-dynamics ; Aqueous-solutions ; Nmr-spectroscopy ; Binding Modes ; Hoechst 33258 ; Dna ; Site ; Drugs ; Water
Keywords plus
Language
english
Publication Year
2013
Prepublished in Year
HGF-reported in Year
2013
ISSN (print) / ISBN
0305-1048
e-ISSN
1362-4962
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 41,
Issue: 7,
Pages: 4159-4170
Article Number: ,
Supplement: ,
Series
Publisher
Oxford University Press
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503000-001
Grants
Copyright
Erfassungsdatum
2013-05-31